Renal amyloidosis secondary to rheumatoid arthritis: remission of proteinuria and renal function improvement with tocilizumab

J Clin Rheumatol. 2013 Jun;19(4):211-3. doi: 10.1097/RHU.0b013e318293793c.
No abstract available

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Amyloidosis / drug therapy*
  • Amyloidosis / etiology
  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Antirheumatic Agents / therapeutic use
  • Arthritis, Rheumatoid / complications*
  • Arthritis, Rheumatoid / drug therapy
  • Blood Sedimentation
  • Female
  • Glomerulonephritis / drug therapy
  • Glomerulonephritis / etiology
  • Hematuria / etiology
  • Humans
  • Kidney Diseases / drug therapy*
  • Kidney Diseases / etiology
  • Middle Aged
  • Proteinuria / drug therapy*
  • Proteinuria / etiology

Substances

  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Adalimumab
  • tocilizumab